Stockreport

Innovation Pharmaceuticals in Discussions to Advance Brilacidin into Human Trials Against COVID-19

INNOVATION PHARMACEUTICAL  (IPIX) 
US:NASDAQ Investor Relations: ipharminc.com/press-release
PDF WAKEFIELD, Mass., April 06, 2020 (GLOBE NEWSWIRE) -- Innovation Pharmaceuticals (OTCQB: IPIX) (“the Company”), a clinical stage biopharmaceutical company, announced to [Read more]